methamphetamine and lobeline

methamphetamine has been researched along with lobeline in 26 studies

Research

Studies (26)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	12 (46.15)	29.6817
2010's	14 (53.85)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Acri, JB; Crooks, PA; Dwoskin, LP; Goldberg, SR; Miller, DK; Munzar, P; Teng, L; Witkin, JM	1
Bardo, MT; Crooks, PA; Dwoskin, LP; Harrod, SB; Klebaur, JE	1
Crooks, PA; Dwoskin, LP	1
Bardo, MT; Dwoskin, LP; Gehrke, BJ; Green, TA; Harrod, SB	1
Eshleman, AJ; Janowsky, A; Johnson, RA; Lysko, PG; Wilhelm, CJ	1
Eyerman, DJ; Yamamoto, BK	1
Crooks, PA; Deaciuc, AG; Dwoskin, LP; Jones, MD; Zheng, G; Zhu, J	1
Kitanaka, J; Kitanaka, N; Morita, Y; Takemura, M; Tatsuta, T	1
Bardo, MT; Crooks, PA; Dwoskin, LP; Harrod, SB; Neugebauer, NM; Stairs, DJ	1
Eshleman, AJ; Janowsky, A; Johnson, RA; Wilhelm, CJ	1
Kitanaka, J	1
Elkashef, A; Hanson, G; Tiihonen, J; Vocci, F; White, J; Wickes, W	1
Crooks, PA; Deaciuc, G; Dwoskin, LP; Krishnamurthy, S; Nickell, JR; Norrholm, S; Siripurapu, KB; Zheng, G	1
Crooks, PA; Dwoskin, LP; Gabriela Deaciuc, A; Vartak, AP	1
Bardo, MT; Beckmann, JS; Crooks, PA; Denehy, ED; Dwoskin, LP; Horton, DB; Nickell, JR; Siripurapu, KB; Vartak, A	1
Bardo, MT; Beckmann, JS; Crooks, PA; Culver, JP; Deaciuc, AG; Dwoskin, LP; Harrod, SB; Hojahmat, M; Horton, DB; Norrholm, SD; Siripurapu, KB	1
Crooks, PA; Dwoskin, LP; Horton, DB; Siripurapu, KB; Zheng, G	1
Bardo, MT; Beckmann, JS; Crooks, PA; Denehy, ED; Dwoskin, LP; Zheng, G	1
Alvers, KM; Bardo, MT; Beckmann, JS; Crooks, PA; Dwoskin, LP; Zheng, G	1
Crooks, PA; Dwoskin, LP; Horton, DB; Nickell, JR; Zheng, G	1
Bardo, MT; Crooks, PA; Dwoskin, LP; Meyer, AC; Neugebauer, NM; Zheng, G	1
Bardo, MT; Crooks, PA; Dwoskin, LP; Wilmouth, CE; Zheng, G	1
Crooks, PA; Dwoskin, LP; Nickell, JR; Siripurapu, KB; Vartak, A	1
Crooks, PA; Ding, D; Dwoskin, LP; Nickell, JR	1
Crooks, PA; Dwoskin, LP; Kangiser, MM; Stairs, DJ; Zheng, G	1
Bardo, MT; Crooks, PA; Dwoskin, LP; Lee, NR; Zheng, G	1

Reviews

4 review(s) available for methamphetamine and lobeline

Article	Year
A novel mechanism of action and potential use for lobeline as a treatment for psychostimulant abuse. Biochemical pharmacology, 2002, Jan-15, Volume: 63, Issue:2 Topics: Amphetamine-Related Disorders; Central Nervous System; Dopamine; Forecasting; Ganglionic Stimulants; Humans; Lobeline; Methamphetamine	2002
[Toxicity of an alkaloid extracted from the plant Lobelia inflata: association with methamphetamine-induced behavioral abnormalities]. Chudoku kenkyu : Chudoku Kenkyukai jun kikanshi = The Japanese journal of toxicology, 2008, Volume: 21, Issue:2 Topics: Animals; Behavior, Animal; Biogenic Monoamines; Brain; Dopamine; Lobelia; Lobeline; Male; Methamphetamine; Mice; Mice, Inbred ICR; Nicotinic Agonists; Rats; Serotonin; Stereotyped Behavior	2008
Pharmacotherapy of methamphetamine addiction: an update. Substance abuse, 2008, Volume: 29, Issue:3 Topics: Antipsychotic Agents; Aripiprazole; Bupropion; Central Nervous System Stimulants; Dextroamphetamine; Drug Therapy; Humans; Lobeline; Methamphetamine; Methylphenidate; Narcotic Antagonists; Nicotinic Agonists; Piperazines; Prevalence; Quinolones; Recurrence; Substance-Related Disorders	2008
The vesicular monoamine transporter-2: an important pharmacological target for the discovery of novel therapeutics to treat methamphetamine abuse. Advances in pharmacology (San Diego, Calif.), 2014, Volume: 69 Topics: Amphetamine-Related Disorders; Animals; Drug Delivery Systems; Drug Discovery; Humans; Lobeline; Methamphetamine; Protein Binding; Treatment Outcome; Vesicular Monoamine Transport Proteins	2014

Other Studies

22 other study(ies) available for methamphetamine and lobeline

Article	Year
Lobeline inhibits the neurochemical and behavioral effects of amphetamine. The Journal of pharmacology and experimental therapeutics, 2001, Volume: 296, Issue:3 Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Analysis of Variance; Animals; Dopamine; Dopamine Agents; Drug Interactions; Electric Stimulation; Ganglionic Stimulants; In Vitro Techniques; Lobeline; Male; Methamphetamine; Motor Activity; Neurochemistry; Rats; Rats, Sprague-Dawley; Visual Cortex	2001
Lobeline attenuates d-methamphetamine self-administration in rats. The Journal of pharmacology and experimental therapeutics, 2001, Volume: 298, Issue:1 Topics: Amphetamine-Related Disorders; Animals; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Lobeline; Male; Methamphetamine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Self Administration; Sucrose	2001
Lobeline does not serve as a reinforcer in rats. Psychopharmacology, 2003, Volume: 165, Issue:4 Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Conditioning, Operant; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Extinction, Psychological; Infusions, Intravenous; Lobeline; Male; Methamphetamine; Nicotinic Agonists; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Self Administration	2003
Effects of methamphetamine and lobeline on vesicular monoamine and dopamine transporter-mediated dopamine release in a cotransfected model system. The Journal of pharmacology and experimental therapeutics, 2004, Volume: 310, Issue:3 Topics: Biological Transport; Cells, Cultured; Dopamine; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Humans; Lobeline; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Nerve Tissue Proteins; Neuropeptides; Nicotinic Agonists; Transfection; Tritium; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins	2004
Lobeline attenuates methamphetamine-induced changes in vesicular monoamine transporter 2 immunoreactivity and monoamine depletions in the striatum. The Journal of pharmacology and experimental therapeutics, 2005, Volume: 312, Issue:1 Topics: Adrenergic Agents; Animals; Biogenic Monoamines; Corpus Striatum; Drug Interactions; Lobeline; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Rats; Rats, Sprague-Dawley; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins	2005
Lobelane analogues as novel ligands for the vesicular monoamine transporter-2. Bioorganic & medicinal chemistry, 2005, Jun-02, Volume: 13, Issue:12 Topics: Animals; Brain Chemistry; Ganglionic Stimulants; Ligands; Lobeline; Membrane Glycoproteins; Membrane Transport Modulators; Membrane Transport Proteins; Methamphetamine; Nicotinic Antagonists; Rats; Receptors, Nicotinic; Structure-Activity Relationship; Substance-Related Disorders; Synaptic Membranes; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins	2005
Lobeline attenuates methamphetamine-induced stereotypy in adolescent mice. Neurochemical research, 2006, Volume: 31, Issue:11 Topics: Animals; Biogenic Monoamines; Brain Chemistry; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Lobeline; Male; Methamphetamine; Mice; Mice, Inbred ICR; Nicotinic Agonists; Stereotyped Behavior	2006
Lobelane decreases methamphetamine self-administration in rats. European journal of pharmacology, 2007, Sep-24, Volume: 571, Issue:1 Topics: Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Infusions, Intravenous; Lobeline; Male; Methamphetamine; Molecular Structure; Motor Activity; Rats; Rats, Sprague-Dawley; Self Administration; Sucrose	2007
Lobeline effects on tonic and methamphetamine-induced dopamine release. Biochemical pharmacology, 2008, Mar-15, Volume: 75, Issue:6 Topics: Amphetamine-Related Disorders; Cell Line; Cocaine; Dopamine; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Humans; Lobeline; Methamphetamine; Nomifensine; Reserpine; Vesicular Monoamine Transport Proteins	2008
Lobelane inhibits methamphetamine-evoked dopamine release via inhibition of the vesicular monoamine transporter-2. The Journal of pharmacology and experimental therapeutics, 2010, Volume: 332, Issue:2 Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine-Related Disorders; Animals; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Drug Evaluation, Preclinical; Lobeline; Male; Methamphetamine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Synaptic Vesicles; Synaptosomes; Vesicular Monoamine Transport Proteins	2010
Quinlobelane: a water-soluble lobelane analogue and inhibitor of VMAT2. Bioorganic & medicinal chemistry letters, 2010, Jun-15, Volume: 20, Issue:12 Topics: Animals; Binding Sites; Dopamine; Humans; Hydrogenation; Hydroquinones; Lobelia; Lobeline; Methamphetamine; Solubility; Structure-Activity Relationship; Substance-Related Disorders; Synaptic Vesicles; Vesicular Monoamine Transport Proteins	2010
The novel pyrrolidine nor-lobelane analog UKCP-110 [cis-2,5-di-(2-phenethyl)-pyrrolidine hydrochloride] inhibits VMAT2 function, methamphetamine-evoked dopamine release, and methamphetamine self-administration in rats. The Journal of pharmacology and experimental therapeutics, 2010, Volume: 335, Issue:3 Topics: 3,4-Dihydroxyphenylacetic Acid; Aconitine; Amphetamine-Related Disorders; Animals; Behavior, Animal; Cell Membrane; Conditioning, Operant; Corpus Striatum; Dopamine; Drug Tolerance; Lobeline; Male; Methamphetamine; Nicotine; Protein Binding; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Reinforcement, Psychology; Self Administration; Synaptic Vesicles; Tetrabenazine; Vesicular Monoamine Transport Proteins	2010
meso-Transdiene analogs inhibit vesicular monoamine transporter-2 function and methamphetamine-evoked dopamine release. The Journal of pharmacology and experimental therapeutics, 2011, Volume: 336, Issue:3 Topics: Animals; Dopamine; Lobeline; Male; Methamphetamine; Rats; Rats, Sprague-Dawley; Self Administration; Vesicular Monoamine Transport Proteins	2011
Novel N-1,2-dihydroxypropyl analogs of lobelane inhibit vesicular monoamine transporter-2 function and methamphetamine-evoked dopamine release. The Journal of pharmacology and experimental therapeutics, 2011, Volume: 339, Issue:1 Topics: Amphetamine-Related Disorders; Animals; Binding, Competitive; Corpus Striatum; Data Interpretation, Statistical; Dopamine; Dopamine Uptake Inhibitors; Kinetics; Lobeline; Male; Methamphetamine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Plasma Membrane Transport Proteins; Structure-Activity Relationship; Synaptic Vesicles; Synaptosomes; Vesicular Monoamine Transport Proteins	2011
The effect of a novel VMAT2 inhibitor, GZ-793A, on methamphetamine reward in rats. Psychopharmacology, 2012, Volume: 220, Issue:2 Topics: Animals; Choice Behavior; Cocaine; Conditioning, Operant; Dose-Response Relationship, Drug; Drug Interactions; Drug Tolerance; Food; Lobeline; Male; Methamphetamine; Neurotransmitter Uptake Inhibitors; Rats; Rats, Sprague-Dawley; Reward; Self Administration; Vesicular Monoamine Transport Proteins	2012
The effect of VMAT2 inhibitor GZ-793A on the reinstatement of methamphetamine-seeking in rats. Psychopharmacology, 2012, Volume: 224, Issue:2 Topics: Amphetamine-Related Disorders; Animals; Drug-Seeking Behavior; Illicit Drugs; Lobeline; Male; Methamphetamine; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Vesicular Monoamine Transport Proteins	2012
GZ-793A, a lobelane analog, interacts with the vesicular monoamine transporter-2 to inhibit the effect of methamphetamine. Journal of neurochemistry, 2013, Volume: 127, Issue:2 Topics: Adrenergic Uptake Inhibitors; Animals; Data Interpretation, Statistical; Dopamine; Dopamine Uptake Inhibitors; Lobeline; Male; Methamphetamine; Neostriatum; Rats; Rats, Sprague-Dawley; Reserpine; Synaptic Vesicles; Tetrabenazine; Vesicular Monoamine Transport Proteins	2013
Effects of VMAT2 inhibitors lobeline and GZ-793A on methamphetamine-induced changes in dopamine release, metabolism and synthesis in vivo. Journal of neurochemistry, 2013, Volume: 127, Issue:2 Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Brain Chemistry; Chromatography, High Pressure Liquid; Data Interpretation, Statistical; Dihydroxyphenylalanine; Dopa Decarboxylase; Dopamine; Dopamine Uptake Inhibitors; Electrochemistry; Extracellular Space; Lobeline; Male; Methamphetamine; Microdialysis; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Tyrosine 3-Monooxygenase; Vesicular Monoamine Transport Proteins	2013
Oral administration of GZ-793A, a VMAT2 inhibitor, decreases methamphetamine self-administration in rats. Pharmacology, biochemistry, and behavior, 2013, Volume: 112 Topics: Administration, Oral; Animals; Dose-Response Relationship, Drug; Lobeline; Male; Methamphetamine; Rats; Rats, Sprague-Dawley; Self Administration; Vesicular Monoamine Transport Proteins	2013
Quinolyl analogues of norlobelane: novel potent inhibitors of [(3)H]dihydrotetrabenazine binding and [(3)H]dopamine uptake at the vesicular monoamine transporter-2. Bioorganic & medicinal chemistry letters, 2015, Jul-01, Volume: 25, Issue:13 Topics: Amphetamine-Related Disorders; Animals; Binding Sites; Dopamine; Humans; In Vitro Techniques; Kinetics; Lobeline; Methamphetamine; Rats; Structure-Activity Relationship; Synaptic Vesicles; Tetrabenazine; Vesicular Monoamine Transport Proteins	2015
Varenicline and GZ-793A differentially decrease methamphetamine self-administration under a multiple schedule of reinforcement in rats. Behavioural pharmacology, 2018, Volume: 29, Issue:1 Topics: Amphetamine-Related Disorders; Animals; Behavior, Addictive; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Lobeline; Male; Methamphetamine; Rats; Rats, Sprague-Dawley; Reinforcement Schedule; Reinforcement, Psychology; Self Administration; Substance-Related Disorders; Varenicline	2018
New Scaffold for Lead Compounds to Treat Methamphetamine Use Disorders. The AAPS journal, 2018, 02-09, Volume: 20, Issue:2 Topics: Administration, Oral; Amphetamine-Related Disorders; Animals; Cardiotoxicity; Disease Models, Animal; Dopamine; Ether-A-Go-Go Potassium Channels; Humans; Lobeline; Locomotion; Male; Methamphetamine; Molecular Structure; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Treatment Outcome; Vesicular Monoamine Transport Proteins	2018